Cardiff Oncology, Inc.
DE ˙ DB ˙ US14147L1089
1,13 € ↓ -0,10 (-7,78%)
2026-06-04
AKTIENPREIS
SecurityDE:XE7C / Cardiff Oncology, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership41,874 shares
Latest Disclosed Value $ 117,666
Group One Trading, L.p. ownership in XE7C / Cardiff Oncology, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 41,874 shares of Cardiff Oncology, Inc. (DE:XE7C) valued at $101,544 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 0 shares of Cardiff Oncology, Inc.. The current value of the position is $47,150 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (XE7C) in the form of stock options. The firm currently holds call options representing 165,600 of underlying shares valued at $465,336 USD and put options representing 9,700 of underlying shares valued at $27,257 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:XE7C / Cardiff Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F CARDIFF ONCOLOGY COM 14147L108 41,874 41,874 118 0.0002
2025-11-12 2025-09-30 13F CARDIFF ONCOLOGY COM 14147L108 0 -2,863 -100.00 0 -100.00
2025-08-14 2025-06-30 13F CARDIFF ONCOLOGY COM 14147L108 2,863 1,990 227.95 9 350.00 0.0000
2025-05-14 2025-03-31 13F CARDIFF ONCOLOGY COM 14147L108 873 -10,563 -92.37 3 -95.92 0.0000
2025-05-14 2024-12-31 13F/A-1 CARDIFF ONCOLOGY COM 14147L108 11,436 -30,158 -72.51 50 -55.86 0.0001
2025-02-14 2024-12-31 13F CARDIFF ONCOLOGY COM 14147L108 11,436 -30,158 50 0.0001
2024-11-14 2024-09-30 13F CARDIFF ONCOLOGY COM 14147L108 41,594 6,818 19.61 111 44.16 0.0003
2024-08-14 2024-06-30 13F CARDIFF ONCOLOGY COM 14147L108 34,776 24,642 243.16 77 42.59 0.0003
2024-05-10 2024-03-31 13F CARDIFF ONCOLOGY COM 14147L108 10,134 -2,243 -18.12 54 200.00 0.0002
2024-02-14 2023-12-31 13F CARDIFF ONCOLOGY COM 14147L108 12,377 -21,827 -63.81 18 -61.70 0.0000
2023-11-09 2023-09-30 13F CARDIFF ONCOLOGY COM 14147L108 34,204 6,228 22.26 48 14.63 0.0002
2023-08-09 2023-06-30 13F CARDIFF ONCOLOGY COM 14147L108 27,976 5,842 26.39 41 13.89 0.0001
2023-05-12 2023-03-31 13F CARDIFF ONCOLOGY COM 14147L108 22,134 22,134 37 0.0001
2023-02-09 2022-12-31 13F CARDIFF ONCOLOGY COM 14147L108 0 -4,619 -100.00 0 -100.00
2022-11-09 2022-09-30 13F CARDIFF ONCOLOGY COM 14147L108 4,619 -31,850 -87.33 7 -91.25 0.0000
2022-08-11 2022-06-30 13F CARDIFF ONCOLOGY COM 14147L108 36,469 -7,085 -16.27 80 -25.93 0.0001
2022-05-12 2022-03-31 13F CARDIFF ONCOLOGY COM 14147L108 43,554 4,903 12.69 108 -53.45 0.0001
2022-02-11 2021-12-31 13F CARDIFF ONCOLOGY COM 14147L108 38,651 -33,668 -46.55 232 -51.87 0.0002
2021-11-12 2021-09-30 13F CARDIFF ONCOLOGY COM 14147L108 72,319 62,696 651.52 482 653.13 0.0005
2021-08-10 2021-06-30 13F CARDIFF ONCOLOGY COM 14147L108 9,623 9,623 64 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CARDIFF ONCOLOGY COM Call 165,600 38.35 465 89.02 n/a n/a n/a
2025-11-12 2025-09-30 13F CARDIFF ONCOLOGY COM Call 119,700 793.28 247 485.71 n/a n/a n/a
2025-08-14 2025-06-30 13F CARDIFF ONCOLOGY COM Call 13,400 -65.19 42 -65.00 n/a n/a n/a
2025-05-14 2025-03-31 13F CARDIFF ONCOLOGY COM Call 38,500 -59.43 121 -70.80 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CARDIFF ONCOLOGY COM Call 94,900 10,444.44 412 20,450.00 n/a n/a n/a
2025-02-14 2024-12-31 13F CARDIFF ONCOLOGY COM Call 94,900 412 n/a n/a n/a
2024-11-14 2024-09-30 13F CARDIFF ONCOLOGY COM Call 900 -79.55 2 -77.78 n/a n/a n/a
2024-08-14 2024-06-30 13F CARDIFF ONCOLOGY COM Call 4,400 -82.68 10 -93.33 n/a n/a n/a
2024-05-10 2024-03-31 13F CARDIFF ONCOLOGY COM Call 25,400 12.89 136 309.09 n/a n/a n/a
2024-02-14 2023-12-31 13F CARDIFF ONCOLOGY COM Call 22,500 -61.99 33 -59.76 n/a n/a n/a
2023-11-09 2023-09-30 13F CARDIFF ONCOLOGY COM Call 59,200 8,357.14 82 8,100.00 n/a n/a n/a
2023-08-09 2023-06-30 13F CARDIFF ONCOLOGY COM Call 700 -87.27 1 -88.89 n/a n/a n/a
2023-05-12 2023-03-31 13F CARDIFF ONCOLOGY COM Call 5,500 1,275.00 9 n/a n/a n/a
2023-02-09 2022-12-31 13F CARDIFF ONCOLOGY COM Call 400 -96.08 1 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F CARDIFF ONCOLOGY COM Call 10,200 -18.40 16 -42.86 n/a n/a n/a
2022-08-11 2022-06-30 13F CARDIFF ONCOLOGY COM Call 12,500 -74.07 28 -76.67 n/a n/a n/a
2022-05-12 2022-03-31 13F CARDIFF ONCOLOGY COM Call 48,200 429.67 120 118.18 n/a n/a n/a
2022-02-11 2021-12-31 13F CARDIFF ONCOLOGY COM Call 9,100 -92.20 55 -92.92 n/a n/a n/a
2021-11-12 2021-09-30 13F CARDIFF ONCOLOGY COM Call 116,600 156.83 777 157.28 n/a n/a n/a
2021-08-10 2021-06-30 13F CARDIFF ONCOLOGY COM Call 45,400 -43.67 302 -59.52 n/a n/a n/a
2021-05-12 2021-03-31 13F CARDIFF ONCOLOGY COM Call 80,600 233.06 746 71.49 n/a n/a n/a
2021-02-10 2020-12-31 13F CARDIFF ONCOLOGY COM Call 24,200 -14.18 435 8.75 n/a n/a n/a
2020-11-12 2020-09-30 13F CARDIFF ONCOLOGY COM Call 28,200 400 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CARDIFF ONCOLOGY COM Put 9,700 -33.56 27 -10.00 n/a n/a n/a
2025-11-12 2025-09-30 13F CARDIFF ONCOLOGY COM Put 14,600 -12.57 30 -42.31 n/a n/a n/a
2025-08-14 2025-06-30 13F CARDIFF ONCOLOGY COM Put 16,700 -52.96 53 -53.15 n/a n/a n/a
2025-05-14 2025-03-31 13F CARDIFF ONCOLOGY COM Put 35,500 -40.64 111 -57.14 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CARDIFF ONCOLOGY COM Put 59,800 102.71 260 232.05 n/a n/a n/a
2025-02-14 2024-12-31 13F CARDIFF ONCOLOGY COM Put 59,800 260 n/a n/a n/a
2024-11-14 2024-09-30 13F CARDIFF ONCOLOGY COM Put 29,500 137.90 79 188.89 n/a n/a n/a
2024-08-14 2024-06-30 13F CARDIFF ONCOLOGY COM Put 12,400 15.89 28 -52.63 n/a n/a n/a
2024-05-10 2024-03-31 13F CARDIFF ONCOLOGY COM Put 10,700 224.24 57 1,325.00 n/a n/a n/a
2024-02-14 2023-12-31 13F CARDIFF ONCOLOGY COM Put 3,300 -5.71 5 0.00 n/a n/a n/a
2023-11-09 2023-09-30 13F CARDIFF ONCOLOGY COM Put 3,500 -96.02 5 -96.90 n/a n/a n/a
2023-08-09 2023-06-30 13F CARDIFF ONCOLOGY COM Put 87,900 9.19 129 -2.27 n/a n/a n/a
2023-05-12 2023-03-31 13F CARDIFF ONCOLOGY COM Put 80,500 133 n/a n/a n/a
2023-02-09 2022-12-31 13F CARDIFF ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F CARDIFF ONCOLOGY COM Put 7,200 -60.00 11 -72.50 n/a n/a n/a
2022-08-11 2022-06-30 13F CARDIFF ONCOLOGY COM Put 18,000 16.88 40 5.26 n/a n/a n/a
2022-05-12 2022-03-31 13F CARDIFF ONCOLOGY COM Put 15,400 87.80 38 -22.45 n/a n/a n/a
2022-02-11 2021-12-31 13F CARDIFF ONCOLOGY COM Put 8,200 -85.06 49 -86.61 n/a n/a n/a
2021-11-12 2021-09-30 13F CARDIFF ONCOLOGY COM Put 54,900 2.81 366 3.10 n/a n/a n/a
2021-08-10 2021-06-30 13F CARDIFF ONCOLOGY COM Put 53,400 292.65 355 181.75 n/a n/a n/a
2021-05-12 2021-03-31 13F CARDIFF ONCOLOGY COM Put 13,600 257.89 126 85.29 n/a n/a n/a
2021-02-10 2020-12-31 13F CARDIFF ONCOLOGY COM Put 3,800 -65.14 68 -56.13 n/a n/a n/a
2020-11-12 2020-09-30 13F CARDIFF ONCOLOGY COM Put 10,900 155 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.